Terms: = Prostate cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
1954 results:
1. Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.
Johansson ALV; Kønig SM; Larønningen S; Engholm G; Kroman N; Seppä K; Malila N; Steig BÁ; Gudmundsdóttir EM; Ólafsdóttir EJ; Lundberg FE; Andersson TM; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
Acta Oncol; 2024 Apr; 63():179-191. PubMed ID: 38597666
[TBL] [Abstract] [Full Text] [Related]
2. Is Unilateral Lymphadenectomy an Option in Selected Patients with prostate cancer?
Kassab BN; De Pablos-Rodríguez P; Ferrer ÁG; García AC; Fons AC; Aragón F; Ramón-Borja JC; Ramírez-Backhaus M
Arch Esp Urol; 2024 Mar; 77(2):129-134. PubMed ID: 38583004
[TBL] [Abstract] [Full Text] [Related]
3. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
[TBL] [Abstract] [Full Text] [Related]
4. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths.
Chang ET; Clarke CA; Colditz GA; Kurian AW; Hubbell E
Cancer Causes Control; 2024 May; 35(5):849-864. PubMed ID: 38238615
[TBL] [Abstract] [Full Text] [Related]
5. Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series.
Thomas H; Chen JJ; Abdul-Baki H; Sabbagh A; Shaheen H; Chau OW; Malik N; Ayoub A; Hassanzadeh C; Hsu IC; Mohamad O
Brachytherapy; 2024; 23(2):173-178. PubMed ID: 38160102
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Capture Rates of the National cancer Database Across Race and Ethnicity.
Satpathy Y; Nam P; Moldovan M; Murphy JD; Wang L; Derweesh I; Rose BS; Javier-DesLoges J
JAMA Netw Open; 2023 Dec; 6(12):e2350237. PubMed ID: 38150248
[TBL] [Abstract] [Full Text] [Related]
7. Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea.
Park SJ; Hong J; Park YJ; Jeong S; Choi S; Chang J; Oh YH; Han M; Ko A; Kim S; Cho Y; Kim JS; Son JS; Park SM
Int J Urol; 2024 Apr; 31(4):325-331. PubMed ID: 38130052
[TBL] [Abstract] [Full Text] [Related]
8. Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study.
Gallagher BDT; Chiam K; Bang A; Patel MI; Kench JG; Edwards S; Nair-Shalliker V; Smith DP
Pathology; 2024 Feb; 56(1):39-46. PubMed ID: 38104002
[TBL] [Abstract] [Full Text] [Related]
9. Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancer.
Ravi P; Kwak L; Devlies W; Xie W; Chipidza F; Yang X; Bubley G; Kaplan I; Kibel AS; Nguyen P; Taplin ME
Prostate; 2024 Mar; 84(4):342-348. PubMed ID: 38041475
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical prostatectomy.
Fukui Y; Yamada Y; Sakamoto S; Horikoshi T; Zhao X; Sato K; Nanba S; Kubota Y; Kanesaka M; Fujimoto A; Shibata H; Goto Y; Sazuka T; Imamura Y; Uno T; Ichikawa T
Anticancer Res; 2023 Dec; 43(12):5705-5712. PubMed ID: 38030183
[TBL] [Abstract] [Full Text] [Related]
11. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract] [Full Text] [Related]
12. prostate cancer treatment in Portugal: a nationwide analysis.
Botelho F; Lopes R; Pina F; Silva C; Pacheco-Figueiredo L; Lunet N
Sci Rep; 2023 Nov; 13(1):19362. PubMed ID: 37938598
[TBL] [Abstract] [Full Text] [Related]
13. Mortality Risk for Docetaxel-Treated, High-Grade prostate cancer With Low PSA Levels: A Meta-Analysis.
Mahal BA; Kwak L; Xie W; Eastham JA; James ND; Sandler HM; Feng FY; Brihoum M; Fizazi K; Sweeney C; Ravi P; D'Amico AV
JAMA Netw Open; 2023 Nov; 6(11):e2340787. PubMed ID: 37910103
[TBL] [Abstract] [Full Text] [Related]
14. Long-term Overall Survival after External Beam Radiotherapy for Localised prostate cancer.
Jahreiβ MC; Incrocci L; Dirkx M; de Vries KC; Aben KKH; Bangma C; Heemsbergen WD
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e689-e698. PubMed ID: 37852813
[TBL] [Abstract] [Full Text] [Related]
15. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant prostate cancer.
Rasmussen KM; Patil V; Li C; Yong C; Appukkuttan S; Grossman JP; Jhaveri J; Halwani AS
JAMA Netw Open; 2023 Oct; 6(10):e2337272. PubMed ID: 37819658
[TBL] [Abstract] [Full Text] [Related]
16. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract] [Full Text] [Related]
17. Long term efficacy of prosthetic inguinal herniorrhaphy concomitant with robot-assisted laparoscopic radical prostatectomy.
Peixoto N; Grobet-Jeandin E; Schoofs F; Windisch O; Iselin C; Benamran D
World J Urol; 2023 Nov; 41(11):3169-3174. PubMed ID: 37755521
[TBL] [Abstract] [Full Text] [Related]
18. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract] [Full Text] [Related]
19. cancer incidence in the US military: An updated analysis.
Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
[TBL] [Abstract] [Full Text] [Related]
20. Genome-wide methylation profiling of diagnostic tumor specimens identified DNA methylation markers associated with metastasis among men with untreated localized prostate cancer.
Chao CR; Slezak J; Siegmund K; Cannavale K; Shu YH; Chien GW; Chen XF; Shi F; Song N; Van Den Eeden SK; Huang J
Cancer Med; 2023 Sep; 12(18):18837-18849. PubMed ID: 37694549
[TBL] [Abstract] [Full Text] [Related]
[Next]
